Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 22-Sep-20 6:03 PM View:  | Athira Pharma, Inc. (ATHA) | 22-Sep-20 | Conversion | 1,644,780 | -- | -- | 400% 411.2K to 2.06M | |
| 22-Sep-20 6:03 PM View: | Athira Pharma, Inc. (ATHA) | 22-Sep-20 | Purchase | 1,058,820 | $17.00 | $18,000,000.00 | 51% 2.06M to 3.11M | |
| 03-Dec-08 2:53 PM View: | XTL Biopharmaceuticals Ltd. (XTLB) | 19-Nov-08 | Market Sale | 9,600,000 | $0.15 | $1,466,880.00 | (32%) 30.18M to 20.58M | 80% |
| 03-Dec-08 2:53 PM View: | XTL Biopharmaceuticals Ltd. (XTLB) | 18-Nov-08 | Market Sale | 30,450,400 | $0.14 | $4,339,610.00 | (50%) 60.63M to 30.18M | 79% |
| 06-Nov-08 12:33 PM View: | Penwest Pharmaceuticals Co. (PPCO.PK) | 24-Oct-08 | Purchase | 3,000 | $5.00 | $15,000.00 | < 1% 6.42M to 6.42M | (80%) |
| 23-Oct-08 7:37 AM View: | Penwest Pharmaceuticals Co. (PPCO.PK) | 15-Oct-08 | Purchase | 300 | $5.00 | $1,500.00 | < 1% 6.42M to 6.42M | (75%) |
| 23-Oct-08 7:37 AM View: | Penwest Pharmaceuticals Co. (PPCO.PK) | 29-Sep-08 | Purchase | 4,500 | $5.00 | $22,500.00 | < 1% 6.42M to 6.42M | (75%) |
| 25-Jul-08 3:40 PM View: | Optimer Pharmaceuticals, Inc. (OPTR) | 02-Jul-08 | Market Sale | 200,000 | $7.40 | $1,480,000.00 | (7%) 2.85M to 2.65M | (73%) |
| 19-Jun-08 12:37 PM View: | XTL Biopharmaceuticals Ltd. (XTLB) | 10-Jun-08 | Market Purchase | 51,000 | $3.23 | $164,730.00 | < 1% 60.58M to 60.63M | (99%) |
| 11-Jun-08 1:30 PM View: | XTL Biopharmaceuticals Ltd. (XTLB) | 09-Jun-08 | Market Purchase | 33,600 | $3.36 | $112,896.00 | < 1% 117.73M to 117.77M | (99%) |
| 11-Jun-08 1:30 PM View: | XTL Biopharmaceuticals Ltd. (XTLB) | 06-Jun-08 | Market Purchase | 100,000 | $3.43 | $343,000.00 | < 1% 117.64M to 117.73M | (99%) |
| 11-Jun-08 1:30 PM View: | XTL Biopharmaceuticals Ltd. (XTLB) | 05-Jun-08 | Market Purchase | 300,000 | $3.22 | $967,000.00 | < 1% 117.33M to 117.64M | (99%) |
| 06-Jun-08 12:47 PM View: | XTL Biopharmaceuticals Ltd. (XTLB) | 04-Jun-08 | Market Purchase | 25,000 | $2.99 | $74,750.00 | < 1% 60.12M to 60.15M | (99%) |
| 06-Jun-08 12:47 PM View: | XTL Biopharmaceuticals Ltd. (XTLB) | 03-Jun-08 | Market Purchase | 400,730 | $3.03 | $1,214,210.00 | < 1% 59.72M to 60.12M | (99%) |
| 20-May-08 3:47 PM View: | Penwest Pharmaceuticals Co. (PPCO.PK) | 15-May-08 | Purchase | 2,500 | $5.00 | $12,500.00 | < 1% 6.29M to 6.3M | (47%) |
| 12-May-08 2:13 PM View: | Penwest Pharmaceuticals Co. (PPCO.PK) | 07-May-08 | Purchase | 2,500 | $5.00 | $12,500.00 | < 1% 6.29M to 6.29M | (48%) |
| 06-May-08 2:51 PM View: | XTL Biopharmaceuticals Ltd. (XTLB) | 02-May-08 | Market Purchase | 50,000 | $3.88 | $194,000.00 | < 1% 59.67M to 59.72M | (99%) |
| 06-May-08 2:51 PM View: | XTL Biopharmaceuticals Ltd. (XTLB) | 01-May-08 | Market Purchase | 105,000 | $3.75 | $393,750.00 | < 1% 59.56M to 59.67M | (99%) |
| 02-May-08 4:20 PM View: | XTL Biopharmaceuticals Ltd. (XTLB) | 30-Apr-08 | Market Purchase | 128,370 | $3.74 | $480,579.00 | < 1% 59.44M to 59.56M | (99%) |
| 02-May-08 4:20 PM View: | XTL Biopharmaceuticals Ltd. (XTLB) | 29-Apr-08 | Market Purchase | 229,240 | $3.54 | $811,028.00 | < 1% 59.24M to 59.47M | (99%) |
| 16-Apr-08 2:33 PM View: | XTL Biopharmaceuticals Ltd. (XTLB) | 10-Apr-08 | Market Purchase | 100,000 | $3.58 | $357,590.00 | < 1% 59.11M to 59.21M | (99%) |
| 04-Apr-08 5:21 PM View: | XTL Biopharmaceuticals Ltd. (XTLB) | 01-Apr-08 | Market Purchase | 301,000 | $3.16 | $951,912.00 | < 1% 58.81M to 59.11M | (99%) |
| 02-Apr-08 4:12 PM View: | XTL Biopharmaceuticals Ltd. (XTLB) | 28-Mar-08 | Market Purchase | 25,000 | $2.90 | $72,460.00 | < 1% 58.78M to 58.81M | (99%) |
| 01-Apr-08 11:23 AM View: | Penwest Pharmaceuticals Co. (PPCO.PK) | 20-Mar-08 | Purchase | 1,340,300 | $5.02 | $6,731,000.00 | 26% 5.22M to 6.56M | (48%) |
| 20-Mar-08 2:55 PM View: | Penwest Pharmaceuticals Co. (PPCO.PK) | 18-Mar-08 | Purchase | 800 | $7.50 | $6,000.00 | < 1% 5.22M to 5.22M | (65%) |
| 20-Mar-08 2:55 PM View: | XTL Biopharmaceuticals Ltd. (XTLB) | 18-Mar-08 | Market Purchase | 163,000 | $3.12 | $508,593.00 | < 1% 58.62M to 58.78M | (99%) |
| 20-Mar-08 2:55 PM View: | XTL Biopharmaceuticals Ltd. (XTLB) | 14-Mar-08 | Market Purchase | 463,000 | $3.33 | $1,540,370.00 | < 1% 58.16M to 58.62M | (99%) |
| 19-Mar-08 4:13 PM View: | XTL Biopharmaceuticals Ltd. (XTLB) | 13-Mar-08 | Market Purchase | 232,180 | $3.38 | $784,180.00 | < 1% 112.99M to 113.23M | (99%) |
| 20-Mar-08 2:55 PM View: | XTL Biopharmaceuticals Ltd. (XTLB) | 13-Mar-08 | Market Purchase | 14,820 | $3.38 | $50,054.00 | < 1% 58.14M to 58.16M | (99%) |
| 20-Mar-08 2:55 PM View: | Penwest Pharmaceuticals Co. (PPCO.PK) | 12-Mar-08 | Purchase | 7,400 | $5.00 | $37,000.00 | < 1% 5.21M to 5.22M | (48%) |
| 19-Mar-08 4:13 PM View: | XTL Biopharmaceuticals Ltd. (XTLB) | 12-Mar-08 | Market Purchase | 413,600 | $3.36 | $1,387,860.00 | < 1% 112.58M to 112.99M | (99%) |
| 20-Mar-08 2:55 PM View: | XTL Biopharmaceuticals Ltd. (XTLB) | 12-Mar-08 | Market Purchase | 26,400 | $3.36 | $88,586.60 | < 1% 58.11M to 58.14M | (99%) |
| 20-Mar-08 2:55 PM View: | Penwest Pharmaceuticals Co. (PPCO.PK) | 11-Mar-08 | Market Purchase | 1,937,900 | $3.17 | $6,137,500.00 | 59% 3.28M to 5.21M | 21% |
| 19-Mar-08 4:13 PM View: | XTL Biopharmaceuticals Ltd. (XTLB) | 11-Mar-08 | Market Purchase | 619,000 | $3.31 | $2,049,120.00 | < 1% 111.96M to 112.58M | (99%) |
| 20-Mar-08 2:55 PM View: | Penwest Pharmaceuticals Co. (PPCO.PK) | 10-Mar-08 | Purchase | 342,200 | $7.42 | $2,540,250.00 | 12% 2.93M to 3.28M | (65%) |
| 19-Mar-08 4:13 PM View: | XTL Biopharmaceuticals Ltd. (XTLB) | 10-Mar-08 | Market Purchase | 1,420,000 | $3.22 | $4,573,930.00 | 2% 61.96M to 63.38M | (99%) |
| 19-Mar-08 4:12 PM View: | XTL Biopharmaceuticals Ltd. (XTLB) | 07-Mar-08 | Market Purchase | 1,150,460 | $3.73 | $4,286,480.00 | 2% 54.28M to 55.43M | (99%) |
| 19-Mar-08 4:12 PM View: | XTL Biopharmaceuticals Ltd. (XTLB) | 06-Mar-08 | Market Purchase | 915,000 | $3.82 | $3,499,490.00 | 2% 53.36M to 54.28M | (99%) |
| 10-Mar-08 2:23 PM View: | Penwest Pharmaceuticals Co. (PPCO.PK) | 05-Mar-08 | Purchase | 52,100 | $5.00 | $260,500.00 | 2% 2.72M to 2.78M | (39%) |
| 10-Mar-08 2:22 PM View: | XTL Biopharmaceuticals Ltd. (XTLB) | 05-Mar-08 | Market Purchase | 570,000 | $3.94 | $2,245,000.00 | < 1% 102.96M to 103.53M | (99%) |
| 10-Mar-08 2:23 PM View: | Penwest Pharmaceuticals Co. (PPCO.PK) | 04-Mar-08 | Purchase | 13,600 | $5.00 | $68,000.00 | < 1% 2.71M to 2.72M | (39%) |
| 10-Mar-08 2:22 PM View: | XTL Biopharmaceuticals Ltd. (XTLB) | 04-Mar-08 | Market Purchase | 410,700 | $3.98 | $1,635,900.00 | < 1% 102.55M to 102.96M | (99%) |
| 29-Feb-08 2:52 PM View: | XTL Biopharmaceuticals Ltd. (XTLB) | 27-Feb-08 | Market Purchase | 110,000 | $4.01 | $441,397.00 | < 1% 52.27M to 52.38M | (99%) |
| 28-Feb-08 2:12 PM View: | XTL Biopharmaceuticals Ltd. (XTLB) | 26-Feb-08 | Market Purchase | 463,180 | $3.91 | $1,811,920.00 | < 1% 51.81M to 52.27M | (99%) |
| 28-Feb-08 3:35 PM View: | XTL Biopharmaceuticals Ltd. (XTLB) | 25-Feb-08 | Market Purchase | 875,000 | $3.87 | $3,383,840.00 | 2% 50.94M to 51.81M | (99%) |
| 28-Feb-08 3:35 PM View: | XTL Biopharmaceuticals Ltd. (XTLB) | 22-Feb-08 | Market Purchase | 1,173,000 | $3.95 | $4,631,770.00 | 2% 49.77M to 50.94M | (99%) |
| 22-Feb-08 3:30 PM View: | Penwest Pharmaceuticals Co. (PPCO.PK) | 20-Feb-08 | Purchase | 600 | $7.50 | $4,500.00 | < 1% 2.71M to 2.71M | |
| 22-Feb-08 3:32 PM View: | XTL Biopharmaceuticals Ltd. (XTLB) | 20-Feb-08 | Market Purchase | 1,000 | $3.84 | $3,840.00 | < 1% 49.76M to 49.76M | (99%) |
| 22-Feb-08 3:30 PM View: | Penwest Pharmaceuticals Co. (PPCO.PK) | 19-Feb-08 | Purchase | 1,500 | $7.50 | $11,250.00 | < 1% 2.71M to 2.71M | |
| 19-Feb-08 3:32 PM View: | XTL Biopharmaceuticals Ltd. (XTLB) | 13-Feb-08 | Market Purchase | 6,000 | $3.81 | $22,849.20 | < 1% 475.63M to 475.64M | (99%) |